Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Biorestorative Therapies, Inc. (BRTX) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$0.02M |
|
$-3.21M |
|
$0.00M |
|
$0.02M |
|
$3.84M |
|
$-3.83M |
|
$0.62M |
|
$-3.21M |
|
$-3.21M |
|
$-3.21M |
|
$-3.21M |
|
$-3.21M |
|
$-3.21M |
|
$-3.83M |
|
$-3.77M |
|
8.99M |
|
8.99M |
|
$-0.31 |
|
$-0.31 |
|
| Balance Sheet Financials | |
$3.14M |
|
$0.36M |
|
$0.94M |
|
$4.08M |
|
$3.72M |
|
-- |
|
-- |
|
$3.72M |
|
$0.34M |
|
$-0.18M |
|
$0.36M |
|
8.88M |
|
| Cash Flow Statement Financials | |
$-10.79M |
|
$8.90M |
|
$2.85M |
|
$0.55M |
|
$1.51M |
|
$0.96M |
|
$3.33M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.84 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
91.65% |
|
-19516.83% |
|
-19516.83% |
|
-- |
|
-16365.48% |
|
-16365.48% |
|
$-10.90M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
1.26 |
|
71.17 |
|
-935.83% |
|
1807.59% |
|
-78.63% |
|
-899.14% |
|
$0.04 |
|
$-1.21 |
|
$-1.20 |
|